Evidence map›Paper›PMID 38033964›Full record

ArticleJournal of oral and maxillofacial pathology : JOMFP

To evaluate the role of lactate dehydrogenase as biomarker in the progression of potentially malignant disorders in smokers and gutkha chewers.

Shivaratna Mediconda, Mohammed Abidullah, Surekha Velidandla

Open access · hybridAbstract read
In one paragraph

Article in Journal of oral and maxillofacial pathology : JOMFP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Shivaratna MedicondaDental Department, Senior Resident at MNJ Cancer Hospital, Redhill, Hyderabad, Telangana, India.
Mohammed AbidullahDepartment of Biomedical Dental Sciences, Faculty of Dentistry, Al Baha University, Saudi Arabia.
Surekha VelidandlaDepartment of Oral Pathology and Microbiology, MNR Dental College and Hospital, Hyderabad, Telangana, India.
Al Baha University · SAMNJ Institute Of Oncology and Regional Cancer Centre · INMNR Dental College and Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: To evaluate the role of lactate dehydrogenase (LDH) as a biomarker in the progression of potentially malignant disorders in smokers and gutkha chewers. Material and Methods: The total of 70 individuals having the habit of chewing gutkha and smoking were selected for the study and divided into four groups. Group 1: 20 individuals having the habit of smoking, Group 2: 20 individuals having the habit of chewing gutkha, Group 3: 20 individuals having the habit of smoking and gutkha chewing, and Group 4: 10 healthy individuals. Results: In the present study showed that unstimulated whole saliva from group 1, group 2, and group 3 individuals, there was a significant decrease in isoenzymes LDH-1 and LDH-2 and there was no effect on LDH-3 isoenzyme. In the present study, there is a significant increase in salivary isoenzyme LDH-4. The result indicated that there is an effect of carcinogen (tobacco)-enhanced activity on salivary LDH. The present study showed 70 volunteers reported a statistical significant correlation among the groups. The individuals with habit of smoking and gutkha chewing showed Conclusion: There was a significant correlation between the levels of salivary LDH isoenzymes and cytomorphometric analysis of oral epithelium in smokers and gutkha chewers.

Indexed as

Gutkha chewersLDHmalignant disorderssmokers

Identifiers

PMID38033964
PMCPMC10683924
OpenAlexW4389244893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.